Lotus Eye Hospital and Institute Limited (LOTUSEYE.NS)
INR 66.03
(0.27%)
INR 66.03
(0.27%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 79.42 Million INR | -25.21% |
| 2022 | 88.36 Million INR | 31.62% |
| 2021 | 68.08 Million INR | 54.28% |
| 2020 | 44.59 Million INR | -9.83% |
| 2019 | 41.14 Million INR | 18.59% |
| 2018 | 36.39 Million INR | -26.56% |
| 2017 | 47.52 Million INR | 38.96% |
| 2016 | 32.62 Million INR | -15.59% |
| 2015 | 45.01 Million INR | 81.86% |
| 2014 | 25.92 Million INR | -29.61% |
| 2013 | 36.46 Million INR | -13.26% |
| 2012 | 44.52 Million INR | 123.26% |
| 2011 | 18.83 Million INR | -44.94% |
| 2010 | 34.19 Million INR | 12.42% |
| 2009 | 30.41 Million INR | -24.34% |
| 2008 | 38.83 Million INR | -4.94% |
| 2007 | 42.29 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 16.64 Million INR | 69.9% |
| 2023 Q2 | 20.83 Million INR | -21.85% |
| 2023 Q1 | 26.66 Million INR | 52.41% |
| 2023 FY | - INR | -25.21% |
| 2023 Q4 | 7.58 Million INR | -51.97% |
| 2023 Q3 | 15.78 Million INR | -24.26% |
| 2022 Q4 | 17.49 Million INR | -28.13% |
| 2022 Q1 | 25.64 Million INR | 78.96% |
| 2022 Q2 | 19.83 Million INR | -22.66% |
| 2022 Q3 | 24.34 Million INR | 22.72% |
| 2022 FY | - INR | 31.62% |
| 2021 FY | - INR | 54.28% |
| 2021 Q1 | 3.39 Million INR | -82.62% |
| 2021 Q2 | 22.99 Million INR | 577.8% |
| 2021 Q3 | 25.68 Million INR | 11.72% |
| 2021 Q4 | 14.33 Million INR | -44.2% |
| 2020 FY | - INR | -9.83% |
| 2020 Q2 | 5.75 Million INR | 723.64% |
| 2020 Q1 | -922 Thousand INR | 54.01% |
| 2020 Q4 | 19.51 Million INR | 4.64% |
| 2020 Q3 | 18.65 Million INR | 224.42% |
| 2019 Q3 | 8.33 Million INR | -55.86% |
| 2019 FY | - INR | 18.59% |
| 2019 Q1 | 22.46 Million INR | 166.15% |
| 2019 Q4 | -2 Million INR | -124.05% |
| 2019 Q2 | 18.88 Million INR | -15.93% |
| 2018 Q1 | 12.99 Million INR | 44.17% |
| 2018 Q4 | 8.44 Million INR | 5.49% |
| 2018 Q3 | 8 Million INR | -1.91% |
| 2018 Q2 | 8.15 Million INR | -37.19% |
| 2018 FY | - INR | -26.56% |
| 2017 Q4 | 9.01 Million INR | -25.45% |
| 2017 Q3 | 12.08 Million INR | -6.71% |
| 2017 Q2 | 12.95 Million INR | -22.85% |
| 2017 Q1 | 16.79 Million INR | 960.74% |
| 2017 FY | - INR | 38.96% |
| 2016 FY | - INR | -15.59% |
| 2016 Q2 | 18.01 Million INR | 5.74% |
| 2016 Q4 | -1.95 Million INR | -130.96% |
| 2016 Q3 | 6.3 Million INR | -65.02% |
| 2016 Q1 | 17.03 Million INR | 454.28% |
| 2015 Q3 | 8.16 Million INR | -38.71% |
| 2015 Q4 | 3.07 Million INR | -62.35% |
| 2015 FY | - INR | 81.86% |
| 2015 Q1 | 20.41 Million INR | 797.27% |
| 2015 Q2 | 13.31 Million INR | -34.76% |
| 2014 Q4 | 2.27 Million INR | -73.66% |
| 2014 FY | - INR | -29.61% |
| 2014 Q1 | 12.26 Million INR | 134.48% |
| 2014 Q2 | 2.49 Million INR | -79.65% |
| 2014 Q3 | 8.63 Million INR | 246.21% |
| 2013 Q3 | 9.24 Million INR | -20.53% |
| 2013 FY | - INR | -13.26% |
| 2013 Q2 | 11.63 Million INR | 12.25% |
| 2013 Q1 | 10.36 Million INR | -12.93% |
| 2013 Q4 | 5.22 Million INR | -43.43% |
| 2012 Q3 | 6.39 Million INR | -36.96% |
| 2012 Q2 | 10.15 Million INR | -31.32% |
| 2012 Q1 | 14.77 Million INR | 529.09% |
| 2012 FY | - INR | 123.26% |
| 2012 Q4 | 11.9 Million INR | 85.98% |
| 2011 Q3 | 5.34 Million INR | 0.0% |
| 2011 FY | - INR | -44.94% |
| 2011 Q4 | -3.44 Million INR | -164.46% |
| 2010 Q4 | 1.45 Million INR | 0.0% |
| 2010 FY | - INR | 12.42% |
| 2009 Q4 | 5.45 Million INR | 0.0% |
| 2009 FY | - INR | -24.34% |
| 2008 Q4 | 9.84 Million INR | 0.0% |
| 2008 FY | - INR | -4.94% |
| 2007 Q4 | 5.85 Million INR | 0.0% |
| 2007 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Apollo Hospitals Enterprise Limited | 24.02 Billion INR | 99.669% |
| Artemis Medicare Services Limited | 1.24 Billion INR | 93.625% |
| Aster DM Healthcare Limited | 6.11 Billion INR | 98.701% |
| Fortis Healthcare Limited | 13.07 Billion INR | 99.393% |
| HealthCare Global Enterprises Limited | 3.5 Billion INR | 97.734% |
| Indraprastha Medical Corporation Limited | 2.1 Billion INR | 96.222% |
| Krishna Institute of Medical Sciences Limited | 6.61 Billion INR | 98.798% |
| Max Healthcare Institute Limited | 16.7 Billion INR | 99.524% |
| Max India Limited | -353.8 Million INR | 122.449% |
| Global Health Limited | 8.71 Billion INR | 99.089% |
| Narayana Hrudayalaya Limited | 12.42 Billion INR | 99.361% |
| Rainbow Children's Medicare Limited | 4.69 Billion INR | 98.308% |
| Shalby Limited | 1.98 Billion INR | 95.99% |